References
Svanborg A. Age-related changes in cardiac physiology: can they be postponed or treated by drugs? Drugs Aging 1997; 10: 463–72
Kreher P, Ristori MT, Corman B, et al. Effects of chronic angiotension I-converting enzyme inhibition on the relations between ventricular action potential changes and myocardial hypertrophy in aging rats. J Cardiovasc Pharmacol 1995; 25: 75–80
Nishimura N, Takase H, Morita T. Effects of chronic losartan treatment on myocardial, vascular structure and reactivity with aging in spontaneously hypertensive rats (SHR): its effects compared with those of captopril. Folia Pharmacol Jap 1995; 105: 479–89
Ferder L, Inserra F, Romano L, et al. Effects of angiotensin-converting enzyme inhibition on mitochondrial number in the aging mouse. Am J Physiol (Cell Physiol) 1993; 265: C15–8
Inserra F, Romano L, Ercolle L, et al. Cardiovascular changes by long-term inhibition of the renin-angiotensin system in aging. Hypertension 1995; 25: 437–42
Lakatta EG. Changes in cardiovascular function in aging. Eur Heart J 1990; 11 Suppl. C: 22–8
Belmin J, Lévy B, Michel JB. Changes in the renin-angiotensin-aldosterone axis in later life. Drugs Aging 1994; 5: 391–400
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Belmin, J. Renin-Angiotensin System and Cardiac Aging. Drugs & Aging 11, 253 (1997). https://doi.org/10.2165/00002512-199711030-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-199711030-00010